We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Ultrasound Molecular Imaging Detects Malignant Cancers

By MedImaging International staff writers
Posted on 21 Apr 2017
Print article
Image: New research suggests labeled microbubbles could help detect malignant cancer (Photo courtesy of Stanford University).
Image: New research suggests labeled microbubbles could help detect malignant cancer (Photo courtesy of Stanford University).
Ultrasound molecular imaging (USMI) in patients with breast and ovarian lesions could provide a new way to diagnose cancer with far fewer biopsies, according to a new study.

Researchers at Stanford University and Agostino Gemelli University Polyclinic conducted a first-in-human clinical trial of USMI in 24 women (48-79 years of age) with breast and ovarian lesions, and 21 women (34-66 years of age) with focal breast lesions, using contrast microbubbles targeted at the kinase insert domain receptor (KDR), one of the key regulators of neoangiogenesis in cancer. The women were injected intravenously with the microbubbles, and USMI of the lesions was performed starting five minutes after injection up to 29 minutes.

The results revealed that KDR expression on immunohistochemistry matched well with imaging signal on USMI in 93% of breast and 85% of ovarian malignant lesions. A strong KDR-targeted USMI signal was present in 77% of malignant ovarian lesions, with no targeted signal seen in 78% of the benign ovarian lesions. Similarly, a strong, targeted signal was seen in 93% of malignant breast lesions, with no targeted signal present in 67% of the benign breast lesions. The study was published on March 14, 2017, in the Journal of Clinical Oncology.

“The difficulty with ultrasound right now is that it detects a lot of lesions in the breast, but most of them are benign. And that leads to many unnecessary biopsies and surgeries,” said lead author professor of radiology Jürgen Willmann, MD, of Stanford University. “Distinguishing benign from malignant tumors with harmless ultrasound imaging could save millions of patients from biopsies they don't need. We could make ultrasound a highly accurate screening technology that is relatively low cost, highly available and with no radiation.”

Medical microbubbles are spheres of phospholipids 1-4 microns in diameter filled with a harmless mixture of perfluorobutane and nitrogen gas. The labeled microbubbles used in the study were designed to bind to KDR, a receptor found only on malignant tumor blood vessels. Under ultrasound imaging, the labeled microbubbles show up clearly when they cluster in such a tumor; as benign breast and ovarian tumors usually lack KDR, the labeled microbubbles mostly passed them by.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Under Table Shield
3 Section Double Pivot Under Table Shield
New
Brachytherapy Planning System
Oncentra Brachy
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.